webcasts

Unmet challenges in systemic therapy (Harold Burstein, USA)
Breast surgery – where do we go? (Michael Gnant, Austria)
What patients want: Tradeoffs, preferences and thresholds (Tanja Spanic, Europa Donna)
Accelerating progress to innovation for patients: Trial design and risk stratification (Meredith Regan, USA)
Global challenges in breast cancer detection and treatment (Carlos Barrios, Brazil)

on-demand lectures:

Webcasts exclusively supported by

Session 2: Care for patients with HER2-positive breast cancer

Neoadjuvant and adjuvant treatment (Nadia Harbeck, Germany)
HER2 heterogeneity (Aleix Prat, Spain)
Can we prevent brain metastases? (Nancy Lin, USA)
Accelerating progress from advanced to early breast cancer (Hope Rugo, USA)

on-demand lectures:

live discussion session:

Webcasts exclusively supported by

Session 3: Care for patients with ER+ breast cancer

Adjuvant endocrine therapy (pre- and postmenopausal) (Eric Winer, USA)
Neoadjuvant endocrine therapy (Steven Johnston, UK)
Why does endocrine therapy work and why does it stop working (Fabrice André, France)
Accelerating progress from advanced to early breast cancer (SERDS, PI3Kinhibitors, other novel agents) (Dave Cescon, Canada

on-demand lectures:

live discussion session:

Webcasts exclusively supported by

Session 4: Predictive and prognostic biomarkers in patients with breast cancer

Tumor infiltrating lymphocytes (Carsten Denkert, Germany)
Genomic changes with therapy and detection of molecular recurrence (Nicholas Turner, UK)
Is lobular breast cancer different and should it be treated differently? (William Gradishar, USA)
Genomic tests for selecting therapy in adjuvant treatment of ER+ breast cancer (Martine Piccart, Belgium)
Genetic testing in patients with triple negative or hereditary breast cancer (Judy Garber, USA)

on-demand lectures:

live discussion session:

Webcasts exclusively supported by

Session 5: Optimal locoregional therapy: treating the axilla in women with breast cancer

Axillary surgery in node-positive breast cancer (Walter Weber, Switzerland)
Omitting surgical staging of the axilla (Tari King, USA)
Risk adapted regional node irradiation (Philip Poortmans, France)
Adjuvant decision making in the era of limited nodal information (Sharon Giordano, USA)

on-demand lectures:

live discussion session:

Webcasts exclusively supported by

Session 6: Local treatment of patients with breast cancer

Standards in breast conservation and oncoplastic surgery (Florian Fitzal, Austria)
Breast surgery after neoadjuvant treatment (Jörg Heil, Germany)
Type/timing of reconstruction when post-mastectomy radiotherapy is planned (Andrea Pusic, USA)
State of the art in DCIS: who needs surgery, radiotherapy, endocrine therapy (Boon Chua, Australia)

on-demand lectures:

live discussion session:

Webcasts exclusively supported by

Session 7: Optimal care for women with triple negative breast cancer

Neoadjuvant and adjuvant treatment (Lisa Carey, USA)
Immuno-oncology treatment in early stage TNBC (Sherene Loi, Australia)
Accelerating progress from advanced to early breast cancer for TNBC (Giuseppe Curigliano, Italy)
Surgery and prophylactic surgery in hereditary breast cancer (Monica Morrow, USA)
PARP inhibitors in treatment of early stage breast cancer (Andrew Tutt, UK)

on-demand lectures:

live discussion session:

Webcasts exclusively supported by

Session 8: Caring for breast cancer survivors

Lifestyle and sexual health (Inez Vaz Luis, France)
Late toxicity of treatment (including bone health) (Bent Ejlertsen, Denmark)
Fertility preservation (Olivia Pagani, Switzerland)
Surveillance and follow-up (Ann Partridge, USA)

on-demand lectures:

live discussion session:

Webcasts exclusively supported by

Session 9: Neoadjuvant approach in patients with early breast cancer

Evaluation of the breast cancer patient (patient assessment, staging, planning) (Isabella Rubio, Spain)
Pathology after neoadjuvant treatment – how to assess residual disease (Giuseppe Viale, Italy)
The meaning of residual disease (Ian Krop, USA)
How to work together – the coordination of the multidisciplinary breast team (Emiel Rutgers, The Netherlands)

on-demand lectures:

live discussion session:

Webcasts exclusively supported by

Session 10: Special treatment challenges in patients with early breast cancer

Management of breast cancer in elderly patients (Matti Aapro, Switzerland)
Management of breast cancer in men (Fatima Cardoso, Portugal)
Locally advanced breast cancer (Stephan Aebi, Switzerland)
Oligometastatic disease – optimal treatment for long-term survival (Javier Cortes, Spain)
Optimizing care in cultures with limited resources: choices and priorities (Andre Ilbawi, WHO Cancer Control Programme)

on-demand lectures:

live discussion session:

Webcasts exclusively supported by

Special Lecture I: Integrating CDK 4-6 in the treatment of patients with early breast cancer (Sibylle Loibl, Germany)

Webcasts exclusively supported by

Webcasts exclusively supported by

Pfizer Oncology Satellite Symposium

> back to top

Pierre Fabre Satellite Symposium